ArticleThe oncologist2023

Dramatic Response to Pyrotinib and T-DM1 in HER2-Negative Metastatic Breast Cancer With 2 Activating HER2 Mutations.

Hao Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.